2026-10-25
TD Synnex clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,990 +1.35%
S&P 7,377 +0.31%
GOLD $4,080 −0.83%
BTC $75,758 −0.24%
VIX 25.64 −9.01%
latest tape · as of 04:01 UTC
The Screen · Technology · Electronics & Computer Distribution
TD Synnex Corp
SNX · the NYSE · USD · 24,000 employees
TD SYNNEX Corporation operates as a distributor and solutions aggregator for the information technology (IT) ecosystem in the United States, Europe, and internationally.
Not yet scored215.37 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 04:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price215.37 USD at the 5 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 5 Nov 2026
- Our regime readDistribution, as of 7 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 10.51)
- Last reviewed5 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $374.00 to $430.74, base estimate $374.00 (screen dated 2026-11-05).
- Trend Distribution
- Insiders insiders sold, $909,794, latest filing 2026-10-22
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 10.51, read 2026-11-05
- Ethical screen not yet scored
Price215.37 USD
Fair value374.00
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-21Read Distribution255.14-15.6% to today ✓Markup gives way to Distribution
2026-09-18Read Markup253.06-14.9% to today Distribution gives way to Markup first Markup read since September
2026-09-17Read Distribution253.06-14.9% to today ✓Markup gives way to Distribution first Distribution read since August
2026-09-13Read Markup253.06-14.9% to today Distribution gives way to Markup first Markup read since July
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
TD Synnex Corp holds its Distribution at $215.37. The statistical read favours the sellers, held for 6 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 6 days |
| Price at the screen | $215.37 |
| Valuation | 20.04 trailing · 13.06 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.44 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 13.46% | Below 33% | Interest-bearing debt is just 13.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 41.29% | Below 49% | Money owed to the company is 41.3% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
TD Synnex clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
TD Synnex clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 13%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 42% discount to our $374.00 fair value, narrow competitive moat, 31.00% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 42.4% discount to the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits +53% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $374.00, with a range of $374.00 to $430.74, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWarehouse scale but thin margins
Picture a vast warehouse shifting laptops, servers and phones from factories to offices across three continents. TD Synnex sits in the middle of that flow, posting 31 percent revenue growth while trading at 11.3 times forward earnings and a 54 percent gap to our fair value. The numbers look attractive on paper.
We still pass. Profit margins sit at just 2 percent, return on equity reaches only 13 percent, and the moat is narrow in a business where customers can switch distributors with little friction. Ethical screens clear, yet the operating model leaves scant room for error once growth normalises.
Distribution volumes move with hardware cycles and inventory swings. A sudden tech slowdown can turn modest margins into losses fast, which is why the low multiple does not signal a bargain here. Analysis, not advice.
| Forward P/E | 13.1xcheap for a company growing this fast |
| Trailing P/E | 20.0xa premium valuation |
| EPS, trailing | 13.95 |
| EPS, forward | 21.41 |
| Revenue growth | +31.0%strong top-line growth |
| Profit margin | 1.6%barely profitable |
| Return on equity | 13.1%a solid return on shareholder capital |
| Dividend yield | 68.00% |
| Debt to equity | 0.53moderate, manageable leverage |
| Current ratio | 1.20adequate liquidity, worth monitoring |
| Beta | 1.44moves a little more than the market |
| Short interest, float | 0.03% |
| 52-week range | 142.22 - 296.47 |
| Moat | NARROW |
| Employees | 24,000 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSNX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-04
Distribution $228.04
-10.6% Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270. Insiders have been net sellers over the past quarter.
2026-10-28
Distribution $255.14
+0.0% Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270. Insiders have been net sellers over the past quarter.
2026-10-21
Distribution · changed $255.14
-6.7% Entry 13
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270.
2026-10-14
Markup $273.37
-2.2% Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270.
2026-10-02
Markup $279.59
+0.0% Entry 11
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270.
2026-09-24
Markup $279.59
+10.5% Entry 10
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-21
Markup $253.06
+0.0% Entry 9
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-19
Markup $253.06
+0.0% Entry 8
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-18
Markup · changed $253.06
+0.0% Entry 7
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-17
Distribution · changed $253.06
+0.0% Entry 6
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- AVT Surges 88.5% in a Year: Should You Buy, Sell or Hold the Stock? Yahoo Finance · 25d ago
- TD SYNNEX (SNX) Could Be 24% Undervalued After Its AI And Space Tech Push Yahoo Finance · 25d ago
- TD SYNNEX's Digital Customers Spend 2X Faster: Can This Drive Growth? Yahoo Finance · 26d ago
- How Investors May Respond To TD SYNNEX (SNX) Expanding Space Tech, AI FinOps And Cybersecurity Partnerships Yahoo Finance · 26d ago
- What Is TD SYNNEX (SNX) Doing In The Space Tech Market? Yahoo Finance · 26d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
AVTAvnet, Inc.
NSITInsight Enterprises, Inc.
CNXNPC Connection, Inc.
SCSCScanSource, Inc.
ARWArrow Electronics Inc
CLMBClimb Global Solutions Inc
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-22 | Dhanji Alim | CHRO | S - Sale | 3,775 | $909,794 |
| 2026-10-21 | Polk Dennis | Chair, Hyve Solutions | S - Sale+OE | 3,955 | $993,773 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $237.02 | +13.0% | · | $1,130 | +13.0% |
| 2 months | $199.22 | +34.4% | $0.48 | $1,346 | +34.6% |
| 3 months | $153.05 | +74.9% | $0.48 | $1,752 | +75.2% |
| 6 months | $156.47 | +71.1% | $0.96 | $1,717 | +71.7% |
| 1 year | $124.78 | +114.6% | $1.84 | $2,160 | +116.0% |
| 2 years | $127.29 | +110.3% | $3.52 | $2,131 | +113.1% |
| 3 years | $89.31 | +199.8% | $5.02 | $3,054 | +205.4% |
| 5 years | $121.46 | +120.4% | $7.32 | $2,264 | +126.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SNX does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.